div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 10button div class=ts-image a href=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5page10jpg target=_blank amp-img class=ts-thumb alt=Page 10: bioslides congresso dstaids curitiba SheilaTeles 201105 · 2011-05-30 · Paciente-fonte HBsAg +HBeAg — Soroconversão após exposição: 22-31% Hepatite B clínica: 1-6% em profissionais src=https:reader040vdocumentspubreader040viewer20220130225f969a0174f3531ff868d67ahtml5thumbnails10jpg width=142 height=106 layout=responsive amp-imga divdiv